GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » TransMedics Group Inc (STU:TMDX) » Definitions » Earnings per Share (Diluted)

TransMedics Group (STU:TMDX) Earnings per Share (Diluted) : €-0.33 (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is TransMedics Group Earnings per Share (Diluted)?

TransMedics Group's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €0.32. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.33.

TransMedics Group's EPS (Basic) for the three months ended in Mar. 2024 was €0.34. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.31.

TransMedics Group's EPS without NRI for the three months ended in Mar. 2024 was €0.32. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.33.

During the past 3 years, the average EPS without NRIGrowth Rate was 12.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 10.60% per year.

During the past 8 years, TransMedics Group's highest 3-Year average EPS without NRI Growth Rate was 20.40% per year. The lowest was -12.20% per year. And the median was 7.10% per year.


TransMedics Group Earnings per Share (Diluted) Historical Data

The historical data trend for TransMedics Group's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TransMedics Group Earnings per Share (Diluted) Chart

TransMedics Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial -2.12 -0.95 -1.42 -1.16 -0.71

TransMedics Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.03 -0.73 0.11 0.32

Competitive Comparison of TransMedics Group's Earnings per Share (Diluted)

For the Medical Devices subindustry, TransMedics Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TransMedics Group's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where TransMedics Group's PE Ratio falls into.



TransMedics Group Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

TransMedics Group's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-22.951-0)/32.517
=-0.71

TransMedics Group's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(11.221-0)/34.679
=0.32

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


TransMedics Group  (STU:TMDX) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


TransMedics Group Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of TransMedics Group's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


TransMedics Group (STU:TMDX) Business Description

Traded in Other Exchanges
Address
200 Minuteman Road, Andover, MA, USA, 01810
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.